These findings demonstrate that EF-24 activates IL-10 signaling–associated transcriptional programs in leukemia cell lines, with both the direction and magnitude of gene expression changes supporting its engagement in tumor-suppressive pathways. The gene discussed is IL10; the disease is neoplasm.